- Condition: Impaired Glucose Tolerance
Interventions: Dietary Supplement: Resveratrol; Dietary Supplement: resveratrol /HMB; Other: Placebo treatment
Sponsors: Vanderbilt University; Vanderbilt University; Nutraceutical Discoveries, Inc.
Recruiting - verified May 2012 - Conditions: Atypical Nevi; Melanoma
Interventions: Drug: broccoli sprout extract - sulforaphane (BSE-SFN); Drug: broccoli sprout extract - sulforaphane (BSE-SFN); Drug: broccoli sprout extract - sulforaphane (BSE-SFN)
Sponsors: University of Pittsburgh; John Kirkwood
Not yet recruiting - verified March 2012 - Conditions: Primary Cutaneous Anaplastic Large Cell Lymphoma,; Mycosis Fungoides
Interventions: Drug: Brentuximab Vedotin; Drug: Methotrexate or Bexarotene
Sponsors: Millennium Pharmaceuticals, Inc.; Millennium Pharmaceuticals, Inc.; Seattle Genetics, Inc.
Recruiting - verified May 2012 - Condition: Solid Tumor
Intervention: Drug: Fenretinide (4-HPR) plus Intravenous Safingol
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center
Not yet recruiting - verified August 2011 - Condition: Recurrent Ovarian Cancer
Intervention: Drug: Ketoconazole and HPR/LXS
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; South Plains Oncology Consortium
Not yet recruiting - verified February 2012 - Condition: Cardiovascular Disease
Interventions: Dietary Supplement: ResA; Dietary Supplement: Resveratrol; Dietary Supplement: Placebo
Sponsors: University of California, Davis; University of California, Davis; Gateway Health Alliance
Not yet recruiting - verified March 2012 - Condition: HDAC Activity
Interventions: Dietary Supplement: Broccoli sprout extract (BSE) placebo; Dietary Supplement: Broccoli sprout extract (BSE) capsules; Dietary Supplement: garlic oil capsules; Dietary Supplement: garlic oil placebo
Sponsors: Oregon State University; Oregon State University
Not yet recruiting - verified February 2012 - Conditions: Ovarian Cancer; Cancer of Ovary; Cancer of the Ovary; Ovary Neoplasms; Primary Peritoneal Carcinoma
Intervention: Drug: Fenretinide/LXS + Ketoconazole
Sponsors: South Plains Oncology Consortium; South Plains Oncology Consortium
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol; Drug: Placebo
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Prostate Cancer
Interventions: Dietary Supplement: Se-methyl-seleno-L-cysteine; Dietary Supplement: selenomethionine; Other: placebo
Sponsors: National Cancer Institute (NCI); Robert H. Lurie Cancer Center; National Cancer Institute (NCI)
Recruiting - verified December 2011 - Conditions: Solid Tumors; Lymphoma; Multiple Myeloma
Intervention: Drug: CS-7017 and Bexarotene
Sponsors: Georgetown University; Georgetown University; Daiichi Sankyo Inc.
Recruiting - verified December 2011 - Condition: Bladder Cancer
Interventions: Drug: Genistein; Drug: Sugar pill
Sponsors: Emory University; Emory University
Not yet recruiting - verified March 2012 - Condition: Neuroendocrine Tumor
Intervention: Dietary Supplement: Resveratrol
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Condition: Autism
Interventions: Drug: Sulforaphane-rich Broccoli Sprout Extract; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Johns Hopkins University
Recruiting - verified January 2012 - Conditions: Monoclonal Gammopathy of Undetermined Significance; Smoldering Multiple Myeloma
Interventions: Dietary Supplement: defined green tea catechin extract; Biological: laboratory biomarker analysis
Sponsors: Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Dry Eye Syndrome
Intervention: Dietary Supplement: Omega 3, Vitamins A, D3 and E
Sponsors: Eye and Vision Technologies and Research Institute; Eye and Vision Technologies and Research Institute; ZeaVision, Inc.
Recruiting - verified March 2012 - Condition: Multiple Sclerosis
Interventions: Dietary Supplement: Polyphenon E; Dietary Supplement: Placebo
Sponsors: National Center for Complementary and Alternative Medicine (NCCAM); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified October 2011 - Condition: HIV Infection
Intervention: Drug: Polyphenon E
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified September 2011 - Conditions: Lip and Oral Cavity Squamous Cell Carcinoma; Oral Cavity Verrucous Carcinoma; Precancerous Condition
Interventions: Drug: vandetanib; Other: placebo; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Procedure: biopsy; Other: pharmacological study
Sponsors: University of Chicago; University of Chicago; National Cancer Institute (NCI)
Not yet recruiting - verified August 2011 - Condition: Impaired Glucose Tolerance
Interventions: Dietary Supplement: resveratrol; Drug: Placebo
Sponsors: Albert Einstein College of Medicine of Yeshiva University; Albert Einstein College of Medicine of Yeshiva University; American Diabetes Association
Recruiting - verified June 2011 - Condition: COPD
Interventions: Dietary Supplement: Sulforaphane 25; Dietary Supplement: Sulforaphane 150; Other: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; Temple University; State University of New York at Buffalo
Recruiting - verified October 2011 - Condition: Prostate Cancer
Interventions: Dietary Supplement: Vitamin D and Genistein; Other: Placebo
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison; University of Alabama at Birmingham; University of Rochester; University of Minnesota - Clinical and Translational Science Institute; Lahey Clinic; Urology San Antonio
Recruiting - verified January 2012 - Condition: Prostate Cancer Prevention
Interventions: Dietary Supplement: sulforaphane glucosinolate capsules; Dietary Supplement: Gelatin capsule containing cellulose and magnesium stearate
Sponsors: Portland VA Medical Center; National Cancer Institute (NCI); Oregon State University; Portland VA Medical Center; OHSU Knight Cancer Institute
Recruiting - verified February 2011 - Condition: Smoking
Interventions: Dietary Supplement: Broccoli sprout homogenate; Dietary Supplement: Alfalfa sprout homogenate
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Conditions: Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Non-Hodgkin's Lymphoma
Interventions: Drug: Fenretinide; Drug: Cytarabine; Drug: Methotrexate
Sponsors: South Plains Oncology Consortium; South Plains Oncology Consortium
Recruiting - verified February 2012 - Conditions: Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma
Interventions: Drug: Pralatrexate Injection; Drug: Bexarotene Capsules; Dietary Supplement: Vitamin B12; Dietary Supplement: Folic Acid
Sponsors: Allos Therapeutics; Allos Therapeutics
Recruiting - verified January 2012 - Conditions: Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage II Prostate Cancer; Stage III Prostate Cancer
Interventions: Dietary Supplement: genistein; Other: placebo; Procedure: therapeutic conventional surgery
Sponsors: Northwestern University; Northwestern University; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Aneurysmal Subarachnoid Hemorrhage
Interventions: Drug: Tiopronin for Hunt Hess grades I-III; Drug: Placebo for Hunt Hess grades I-III; Drug: Placebo for Hunt Hess grades IV-V; Drug: Tiopronin for Hunt Hess grades IV-V
Sponsors: Columbia University; Columbia University; University of Florida; University of Washington
Recruiting - verified January 2012 - Conditions: Chronic Hepatitis C; Oxidative Stress
Interventions: Dietary Supplement: silymarin; Dietary Supplement: green tea extract (EGCG)
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Center for Complementary and Alternative Medicine (NCCAM); National Institutes of Health (NIH)
Recruiting - verified November 2011 - Condition: Refractory Cutaneous T-cell Lymphoma
Interventions: Drug: bexarotene; Drug: bexarotene
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified January 2012 - Condition: Leukemia, Myeloid, Acute
Interventions: Drug: Decitabine and Bexarotene; Drug: Decitabine and Bexarotene; Drug: Decitabine and Bexarotene
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified October 2011 - Condition: Breast Cancer
Interventions: Drug: Broccoli sprout extract (sulforaphane); Dietary Supplement: Mango juice without extract
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center; Breast Cancer Research Foundation
Recruiting - verified January 2012 - Conditions: Leukemia; Lymphoproliferative Disorders
Intervention: Drug: Phenethyl Isothiocyanate (PEITC)
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Not yet recruiting - verified January 2012 - Conditions: Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition
Interventions: Dietary Supplement: defined green tea catechin extract; Genetic: gene expression analysis; Genetic: protein analysis; Other: laboratory biomarker analysis
Sponsors: Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified November 2011 - Condition: Breast Cancer
Interventions: Drug: Green tea extract supplement; Other: Placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified January 2012 - Conditions: Breast Cancer; Dermatitis
Interventions: Other: Sulforaphane-containing broccoli sprout extracts (active agent); Device: Vehicle (inactive control)
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified April 2012 - Condition: Prostate Cancer
Interventions: Drug: oral microencapsulated diindolylmethane; Other: high performance liquid chromatography; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: mass spectrometry; Procedure: neoadjuvant therapy; Procedure: therapeutic conventional surgery
Sponsors: Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified November 2011 - Conditions: Lung Cancer; Tobacco Use Disorder
Interventions: Drug: phenethyl isothiocyanate; Other: placebo
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Acute Myeloid Leukemia
Intervention: Drug: Bexarotene
Sponsors: University of Pennsylvania; University of Pennsylvania
Recruiting - verified December 2011 - Condition: Prostate Cancer
Interventions: Dietary Supplement: cholecalciferol; Dietary Supplement: genistein; Dietary Supplement: soy isoflavones; Genetic: polymerase chain reaction; Genetic: protein expression analysis; Other: immunologic technique; Other: laboratory biomarker analysis
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Hypertension; Obesity; Type 2 Diabetes; Insulin Resistance
Interventions: Drug: Dietary Supplement: epigallocatechin 3-gallate (EGCG); Procedure: hyperinsulinemic isoglycemic glucose clamp; Procedure: insulin-stimulated brachial artery blood flow; Procedure: assess capillary recruitment in forearm skeletal muscle
Sponsors: University of Maryland; University of Maryland; Office of Dietary Supplements (ODS); National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified December 2011 - Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: fenretinide; Other: pharmacological study
Sponsors: California Cancer Consortium; California Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified February 2012
 |
Anti Carcinogenic Agents Clinical Trials |
